Intrinsic Value of S&P & Nasdaq Contact Us

DICE Therapeutics, Inc. DICE NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
43/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$60.00
+26.2%

DICE Therapeutics, Inc. (DICE) has 13 known insider and institutional holders on record. The largest holder is RA CAPITAL MANAGEMENT, L.P. with 6,807,839 shares. Other notable holders include Judice Kevin and Robertson Scott M..

DICE Insider Ownership

Top Holder
RA CAPITAL MANAGEMENT, L.P.
6,807,839 shares
Buys (12 mo)
0
$0.00 value
Sells (12 mo)
0
$0.00 value
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Ra Capital Management, L.p. 10 Percent Owner 6,807,839 2023-03-30
100%
2 Judice Kevin CEO 799,685 2023-05-05
12%
3 Robertson Scott M. CFO & Cbo 198,000 2023-05-05
3%
4 Northpond Ventures Gp, Llc 10 Percent Owner 166,293 2023-06-23
2%
5 Timothy Lu CMO 152,285 2023-05-05
2%
6 Jacobsen John R. CSO 147,497 2023-06-02
2%
7 Doyle Mittie Director 42,500 2022-04-01
1%
8 Bowers Lisa Director 42,500 2022-04-01
1%
9 Scopa James Paul Director 25,722 2023-08-03
0%
10 Shah Rajeev M. Director 21,250 2022-06-08
0%
11 Tetlow Sharon Director 21,250 2022-06-08
0%
12 Simson Jake Director 21,250 2022-06-08
0%
13 Scheller Richard H Director 8,427 2023-05-09
0%

No ownership data available for DICE.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message